This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignees: Biomerieux, Inc., National Institute of Health and Medical Research. Active years: 2008.
Company Filing History:
1 out of 645 
1 out of 1,853 
Years Active: 2008
Title: Jean-Luc Blond: Innovator in Retroviral Research
Introduction
Jean-Luc Blond is a notable inventor based in Lyons, France. He has made significant contributions to the field of retroviral research, particularly in the detection of human endogenous retroviruses. His innovative work has implications for understanding viral interactions and their effects on human health.
Latest Patents
Jean-Luc Blond holds a patent titled "Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein." This patent describes a method for detecting the expression of a polypeptide in cells and for identifying the interaction between a polypeptide and cells, either ex vivo or in vitro. The polypeptide is selected from a specific group, including peptides related to the envelope protein of the human endogenous retrovirus, HERV-W. Detection is established through the fusogenic power of the polypeptide, demonstrated by syncytia formation. He has 1 patent to his name.
Career Highlights
Throughout his career, Jean-Luc Blond has worked with prominent organizations such as Biomerieux, Inc. and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Jean-Luc Blond has collaborated with notable colleagues, including Francois Mallet and Francois-Loic Cosset. These partnerships have enriched his research and expanded the impact of his work in the field.
Conclusion
Jean-Luc Blond's innovative contributions to retroviral research and his patent on detecting envelope proteins highlight his role as a significant inventor in the scientific community. His work continues to influence the understanding of human endogenous retroviruses and their implications for health.